VI
MED icon

Vestcor Inc’s Medifast MED Stock Holding History

Vestcor Inc’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-465
Closed -$8K – 1234
2024
Q4 		$8K Hold
465
– – ﹤0.01% 1168
2024
Q3 		$9K Hold
465
– – ﹤0.01% 1112
2024
Q2 		$10K Sell
465
-14,558
-97% -$388K ﹤0.01% 1110
2024
Q1 		$576K Sell
15,023
-8,083
-35% -$391K 0.02% 609
2023
Q4 		$1.55M Buy
23,106
+335
+1% +$23.3K 0.05% 339
2023
Q3 		$1.7M Sell
22,771
-5,598
-20% -$497K 0.06% 302
2023
Q2 		$2.61M Buy
28,369
+12,887
+83% +$1.15M 0.1% 234
2023
Q1 		$1.6M Buy
15,482
+9,849
+175% +$1.09M 0.06% 330
2022
Q4 		$650K Buy
5,633
+2,166
+62% +$252K 0.02% 593
2022
Q3 		$376K Sell
3,467
-4,218
-55% -$604K 0.01% 748
2022
Q2 		$1.39M Hold
7,685
– – 0.05% 414
2022
Q1 		$1.31M Buy
+7,685
New +$1.45M 0.05% 423
2021
Q4 		– Sell
-11,409
Closed -$2.2M – 1442
2021
Q3 		$2.2M Buy
11,409
+5,373
+89% +$1.32M 0.08% 260
2021
Q2 		$1.71M Buy
6,036
+1,327
+28% +$360K 0.06% 347
2021
Q1 		$997K Buy
+4,709
New +$1.13M 0.04% 455

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vestcor Inc's MED Position: Q1 2025 in Review

Vestcor Inc sold out of Medifast (MED) in Q1 2025, closing a stake of 465 shares — an estimated $8K sold.

Vestcor Inc first reported a position in MED in Q1 2021 and held it in 15 quarters. The position peaked at $2.61M in Q2 2023. 124 funds tracked by Wall St. Rank hold MED as of Q1 2025.

  • Vestcor Inc reported no remaining Medifast position as of Q1 2025 after selling out during the quarter.
  • Vestcor Inc sold 465 Medifast shares in Q1 2025, an estimated $8K.
  • Vestcor Inc first reported a position in Medifast in Q1 2021 and held it in 15 quarters.
  • Vestcor Inc's Medifast position peaked at $2.61M in Q2 2023.
  • 124 funds tracked by Wall St. Rank held Medifast as of Q1 2025.

Based on Vestcor Inc's 13F filing for Q1 2025, filed 8 May 2025.